Recombinant Human Leukotriene A4 Hydrolase/LTA4H Protein, CF

Catalog #: 4008-ZN Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
4008-ZN-010

R&D Systems Recombinant Proteins and Enzymes

1 Image

All Leukotriene A4 Hydrolase/LTA4H Proteins and Enzymes

Product Details

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Leukotriene A4 Hydrolase/LTA4H Protein, CF Summary

Product Specifications

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its ability to cleave the fluorogenic peptide substrate, Arg-7-amido-4-methylcoumarin (R-AMC). The specific activity is >70 pmol/min/µg, as measured under the described conditions.

Source

Spodoptera frugiperda, Sf 21 (baculovirus)-derived human Leukotriene A4 Hydrolase/LTA4H protein
Pro2-Asp611, with a C-terminal 10-His tag

Accession #

P09960

N-terminal Sequence
Analysis

Pro2

Predicted Molecular Mass

70 kDa

SDS-PAGE

71 kDa, reducing conditions

Product Datasheets

4008-ZN

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

4008-ZN

Formulation	Supplied as a 0.2 μm filtered solution in Tris, NaCl, and Glycerol.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials

Assay Buffer: 50 mM Tris, 150 mM NaCl, 10 mM CaCl₂, pH 7.5 (TCN)
Recombinant Human Leukotriene A4 Hydrolase/LTA4H (rhLTA4H) (Catalog # 4008-ZN)
Substrate: H-Arg-AMC (Bachem, Catalog # I-1050 or ChemImpex, Catalog # 5859), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent

Dilute rhLTA4H to 10 µg/mL in Assay Buffer.
Dilute Substrate to 800 µM in Assay Buffer.
Load 50 µL of 10 µg/mL rhLTA4H into a plate, and start the reaction by adding 50 µL of 800 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of Substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Calculate specific activity:

Specific Activity (pmol/min/µg) =	Adjusted V_max* (RFU/min) x Conversion Factor** (pmol/RFU)
	amount of enzyme (µg)

*Adjusted for Substrate Blank

**Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC) (Sigma-Aldrich, Catalog # A9891).

Per Well:

rhLTA4H: 0.5 µg
Substrate: 400 µM

Reconstitution Calculator

Background: Leukotriene A4 Hydrolase/LTA4H

Leukotrienes are a family of lipid mediators important in a variety of allergic and inflammatory reactions. Synthesized by leukocytes, these molecules are divided into two classes, the spasmogenic cysteinyl leukotrienes and LTB4, a classical chemoattractant (1). Encoded by the LTA4H gene, Leukotriene A4 Hydrolase catalyzes the conversion of unstable epoxide LTA4 to LTB4, which is the final and committed step in LTB4 biosynthesis. As a bifunctional zinc metalloenzyme, LTA4H also acts as an arginyl aminopeptidase (2). LTA4H is a drug target for anti-inflammation, and for cancer prevention and therapy (1, 3).

The mature chain of human LTA4H consists of 610 amino acids (residues 2-611). It is highly specific for LTA4, which also covalently modifies and inhibits the enzyme. The aminopeptidase activity is enhanced by monovalent anions (1). R&D Systems recombinant human LTA4H corresponds to the mature chain, and is characterized by its arginyl aminopeptidase activity.

References